Download presentation
Presentation is loading. Please wait.
Published byColin McDonough Modified over 11 years ago
1
ECONOMIA DELLINNOVAZIONE LINNOVAZIONE NELLINDUSTRIA FARMACEUTICA parte I Prof. Stefano Capri Istituto di Economia Università Carlo Cattaneo-LIUC
2
S.Capri - LIUC University
9
Top worldwide pharmaceutical companies
10
S.Capri - LIUC University Revenue drivers R&D pipeline New drugs introduction rate Sales network Relationship network
11
S.Capri - LIUC University Cost drivers R&D Promotion Salesnetwork
12
S.Capri - LIUC University
13
Promotion
14
S.Capri - LIUC University Competitive environment The increase of cost and length of the R&D process The increase of internal competition The advent of generic medicines The expiration of patents The price regulation The advent of personalised medicines
15
S.Capri - LIUC University From Laboratory to Patient: The Complex Pathway of Biopharmaceutical R&D Pharmaceutical Industry Profile 2005 (Washington, DC: PhRMA, March 2005).
16
S.Capri - LIUC University Biopharmaceutical R&D Expenditures and NIH Budget: 1994–2004 Pharmaceutical Industry Profile 2005 (Washington, DC: PhRMA, March 2005).
17
S.Capri - LIUC University The period of market exclusivity between the introduction of a breakthrough medicine and of a competing product is rapidly shrinking
18
S.Capri - LIUC University The expiration of patents Generic erosion
19
S.Capri - LIUC University Price differences among European countries
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.